الفهرس 
INTRODUCTION and RATIONALEOnly 14 pages are availabe for public view
 |  | from | 127 |  |  |
| | | from | 127 | | |
Abstract
Diabetic patients who fast during Ramadan may alter their medicines schedule without seeking medical advice from healthcare professionals. Healthcare professionals need to educate such patients by providing structured education and counseling to avoid the risk of developing DRPs.
With so many Muslims with diabetes choosing to fast during Ramadan, potentially in some, against medical advice, there is an immediate need for practical management guidelines that enable HCPs to offer the most up-to-date information, advise patients if fasting should not be undertaken, and support those that do fast. A pre-Ramadan assessment is vital for any patient with diabetes who intends to fast in order to evaluate the risks, educate the patient in self-management of the condition during Ramadan and to produce a patient-specific treatment plan describing any medication adjustments needed. Ramadan-focused education and a better knowledge of nutrition during Ramadan are essential elements for safer fasting during Ramadan.
The IDF-DAR Practical Guidelines propose three categories of risk, with patients stratified to the very high- or high-risk groups being advised not to fast. With the correct advice and support from HCPs, many people with T2DM may be able to fast safely during Ramadan. Patients taking metformin, SUs or insulin will need to make adjustments to dose and/or timings to reduce the risk of complications. Newer anti-glycemic medications, including incretin-based therapies, are associated with a lower risk of hypoglycemia and may be preferable for use during Ramadan. Patients classified as very high or high risk, including those with T1DM and pregnant women with diabetes, need close medical supervision if they insist on Ramadan fasting.
82
The implementation of these guidelines will require the involvement of religious leaders in community alongside HCPs, to ensure that patients receive